Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...

In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...

MUMBAI, (IANS) – Pharma major Lupin Limited has said that it has launched Mirabegron extended-release tablets, 25 mg, in the US market, after having received approval from the Food and Drug ...

TORONTO - Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...

Did our AI summary help? Hetero has begun exporting generic versions of semaglutide, accelerating competition in the global market for diabetes and obesity medicines as demand for GLP‑1 therapies ...

Eli Lilly's market share in India's weight‑loss drug market fell to 56% in March from 61% in February. Novo Nordisk's market share remained steady at 25%. Indian generic drugmakers have launched 26 ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novo Nordisk (NVO) (NONOF) has once again reduced the prices of its GLP-1 medicine, semaglutide, in India as the company grapples with cheaper copycat versions of the popular GLP-1 therapy marketed as ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

In this article we highlight the important role that medication therapy can play in preventing disease and controlling costs. Focusing on coronary artery disease, we demonstrate that prevention, with ...